The binding site of NK receptors on HLA-C molecules

Immunity

Volumn 6, Issue 3, 1997, Pages 341-350

  Mandelboim, Ofer ^a   Reyburn, Hugh T ^a   Sheu, Eric G ^a   Valés Gómez, Mar ^a   Davis, Daniel M ^a   Pazmany, Laszlo ^a   Strominger, Jack L ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA C ANTIGEN; HLA DR ANTIGEN;

ARTICLE; BINDING SITE; HLA SYSTEM; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS;

EID: 0030964117     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80336-2     Document Type: Article

References (43)

1. Barber, D.L., Percival, L., Valiante, M.N., Chen, L., Lee, C., Gumperz, J.E., Phillips, J.H., Lanier, L.L., Begge, C.J., Parekh, B.R., and Parham, P. (1996). The inter-locus recombinant HLA-B*4601 has high selectivity in peptide binding and functions characteristic of HLA-C. J. Exp. Med. 184, 735-740.
2. Biassoni, R., Falco, M., Canbiaggi, A., Costa, P., Verdiani, S., Pende, D., Conte, R., Di Donato, C., Parham, P., and Moretta, L. (1995). Amino-acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules: role of serine 77 and lysine 80 in the target cells protection from lysis mediated by 'group 1' or 'group 2' NK clones. J. Exp. Med. 182, 605-609.
3. Biassoni, R., Cantoni, C., Falco, M., Verdiani, S., Bottino, C., Vitale, M., Conte, R., Poggi, A., Moretta, A., and Moretta, L. (1996). The human leukocyte antigen (HLA)-C-specific 'activatory' or 'inhibitory' natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J. Exp. Med. 184, 645-650.
4. Bjorkman, P., Saper, M., Samraoui, B., Bennett, W., Strominger, J., and Wiley, D. (1987). Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329, 506-512.
5. Burmeister, W.P., Gastinel, L.N., Simister, N.E., Blum, M.L., and Bjorkman, P.J. (1994a). Crystal structure at 2.2 Å resolution of the MHC-related neonatal Fc receptor. Nature 372, 336-343.
6. Burmeister, W.P., Huber, A.H., and Bjorkman, P.J. (1994b). Crystal structure of the complex of rat neonatal Fc receptor with Fc. Nature 372, 379-383.
7. Burshtyn, D.N., Scharenberg, A.M., Wagtmann, N., Rajagopalan, S., Berrada, K., Yi, T., Kinet, J.-P., and Long, E.O. (1996). Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity 4, 77-85.
8. Cammarota, G., Scheirle, A., Takacs, B., Doran, D.M., Knorr, R., Bannwarth, W., Guardiola, J., and Sinigaglia, F. (1992). Identification of a CD4 binding site on the β2 domain of HLA-DR molecules. Nature 356, 799-801.
9. Campbell, K.S., Dessing, M., Lopez-Botet, M., Cella, M., and Colonna, M. (1996). Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C. J. Exp. Med. 184, 93-100.
10. Cella, M., Longo, A., Ferrara, G.B., Strominger, J.L., and Colonna, M. (1994). NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J. Exp. Med. 180, 1235-1242.
11. Chambers, B., Salcedo, M., and Ljunggren, H.-G. (1996). Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1). Immunity 5, 311-317.
12. Colonna, M., and Samaridis, J. (1995). Cloning of immunoglobulin superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 268, 405-408.
13. Colonna, M., Borsellino, G., Falco, M., Ferrara, G.B., and Strominger, J.L. (1993a). HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc. Natl. Acad. Sci. USA 90, 12000-12004.
14. Colonna, M., Brooks, E.G., Falco, M., Ferrara, G.B., and Strominger, J.L. (1993b). Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C. Science 260, 1121-1124.
15. D'Andrea, A., Chang, C., Franz-Bacon, K., McClanaham, T., Phillips, J.H., and Lanier, L.L. (1995). Molecular cloning of NKB1: a natural killer cell receptor for HLA-B allotypes. J. Immunol. 155, 2306-2313.
16. Dohring, C., Scheidegger, D., Samaridis, J., Cella, M., and Colonna, M. (1996). A human killer inhibitory receptor specific for HLA-A. J. Immunol. 156, 3098-3101.
17. Fry, A.M., Lanier, L.L., and Weiss, A. (1996). Phosphotyrosines in the killer cell inhibitory receptor motif are required for negative signaling and for association with protein tyrosine phosphatase 1C. J. Exp. Med. 184, 295-300.
18. Garboczi, D.N., Ghosh, P., Utz, U., Fan, Q.R., Biddison, W.E., and Wiley, D.C. (1996). Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384, 134-141.
19. Garcia, K.C., Degano, M., Stanfield, R.L., Brunmark, A., Jackson, M.R., Peterson, P.A., Teyton, L., and Wilson, I.A. (1996). An α/β T cell receptor structure at 2.5 Å and its orientation in the TCR-MHC complex. Science 274, 209-219.
20. Gumperz, J.E., Litwin, V., Phillips, J.H., Lanier, L.L., and Parham, P. (1995). The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J. Exp. Med. 181, 1133-1144.
21. Jardetzky, T.S., Brown, J.H., Gorga, J.C., Stern, L.J., Urban, R.G., Chi, Y.-I., Stauffacher, C., Strominger, J.L., and Wiley, D.C. (1994). Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 368, 711-718.
22. Kim, J., Urban, R.G., Strominger, J.L., and Wiley, D.C. (1994). Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. Science 266, 1870-1874.
23. Konig, R., Huang, L.-Y., and Germain, R.N. (1992). MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8. Nature 356, 796-798.
24. Ljunggren, H.-G., and Karre, K. (1990). In search of the'missing self': MHC molecules and NK recognition. Immunol. Today 11, 237-242.
25. Luque, I., Solana, R., Galiani, M.D., Gonzalez, R., Garcia, F., Lopez de Castro, J.A., and Pena, J. (1996). Threonine 80 on HLA-B27 confers protection against lysis by a group of natural killer clones. Eur. J. Immunol. 26, 1974-1977.
26. Mandelboim, O., Davis, D.M., Reyburn, H.T., Vales-Gomez, M., Sheu, E.G., Pazmany, L., and Strominger, J.L. (1996a). Enhancement of class II-restricted T cell responses by co-stimulatory NK receptors for class I MHC proteins. Science 274, 2097-2100.
27. Mandelboim, O., Reyburn, H.T., Vales-Gomez, M., Pazmany, L., Colonna, M., Borsellino, G., and Strominger, J.L. (1996b). Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J. Exp. Med. 184, 913-922.
28. Moretta, A., Vitale, M., Bottino, C., Orengo, A.M., Morelli, L., Augugliaro, R., Barbaresi, M., Ciccone, E., and Moretta, L. (1993). p58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells: anti-p58 antibodies reconstitute lysis of MHC class I protected cells in NK clones displaying different specificities. J. Exp. Med. 178, 597-604.
29. Moretta, A., Sivori, S., Vitale, M., Pende, D., Morelli, L., Augugliaro, R., Bottino, C., and Moretta, L. (1995). Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J. Exp. Med. 182, 875-884.
30. Olcese, L., Lang, P., Vely, F., Cambiaggi, A., Marguet, D., Blery, M., Hippen, K.L., Biassoni, R., Moretta, A., Moretta, L., Cambier, J.C., and Vivier, E. (1996). Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J. Immunol. 156, 4531-4534.
31. Parham, P., Arnett, K.L., Adams, E.J., Barber, L.D., Domena, J.D., Stewart, D., Hildebrand, W.H., and Little, A.-M. (1994). The HLA-B73 antigen has a most unusual structure that defines a second lineage of HLA-B alleles. Tissue Antigens 43, 302-313.
32. Pazmany, L., Mandelboim, O., Vales-Gomez, M., Davis, D.M., Reyburn, H.T., and Strominger, J.L. (1996). Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science 274, 792-795.
33. Pende, D., Biassoni, R., Cantoni, C., Verdiani, S., Falco, M., Di Donato, C., Accame, L., Bottino, C., Moretta, A., and Moretta, L. (1996). The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterised by three immunoglobulin like domains and is expressed as a 140-kd disulphide linked dimer. J. Exp. Med. 184, 505-518.
34. Peruzzi, M., Parker, K., Long, E., and Malnati, M. (1996). Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells. J. Immunol. 157, 3350-3356.
35. Phillips, J.H., Gumperz, J.E., Parham, P., and Lanier, L. (1995). Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science 268, 403-405.
36. Salter, R.D., Benjamin, R.J., Wesley, P.K., Buxton, S.E., Garrett, T.P., Clayberger, C., Krensky, A.M., Norment, A.M., Littman, D.R., and Parham, P. (1990). A binding site for the T-cell co-receptor CD8 on the α3 domain of HLA-A2. Nature 345, 41-46.
37. Sanchez, M.J., Muench, M.O., Roncarolo, M.G., Lanier, L.L., and Phillips, J.G. (1994). Identification of a common T/natural killer cell progenitor in human fetal thymus. J. Exp. Med. 180, 569-576.
38. Shimizu, Y., and DeMars, R. (1989). Production of human cells expressing individual transferred HLA-A, -B, -C genes using an HLA-A, -B, -C null human cell line. J. Immunol. 142, 3320.
39. Spits, H., Lanier, L.L., and Phillips, J.H. (1995). Development of human T and natural killer cells. Blood 85, 2654-2670.
40. Townsend, A., and Bodmer, H. (1989). Antigen recognition by class I-restricted T lymphocytes. Annu. Rev. Immunol. 7, 601-624.
41. Trinchieri, G. (1989). Biology of natural killer cells. Adv. Immunol. 47, 187-376.
42. Vilches, C., de Pablo, R., Herrero, M.J., Moreno, M.E., and Kreisler, M. (1994). HLA-B73: an atypical HLA-B molecule carrying a Bw6-epitope motif variant and a B pocket identical to HLA-B27. Immunogenetics 40, 166.
43. Wagtmann, N., Biassoni, R., Cantoni, C., Verdiani, S., Malnati, M.S., Vitale, M., Bottino, C., Moretta, L., Moretta, A., and Long, E.O. (1995). Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intra-cellular domains. Immunity 2, 439-449.